Cargando…

theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions

Tight junctions (TJ) are formed by transmembrane and intracellular proteins that seal the intercellular space and control selective permeability of epithelia. Integrity of the epithelial barrier is central to tissue homeostasis and barrier dysfunction has been linked to many pathological conditions....

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Teresa Lopes, de Oliveira-Marques, Virgínia, Hampson, Richard John, Jacinto, António, de Moraes, Luciana Vieira, Martinho, Rui Gonçalo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771259/
https://www.ncbi.nlm.nih.gov/pubmed/35069190
http://dx.doi.org/10.3389/fphar.2021.752787
_version_ 1784635562465951744
author Gomes, Teresa Lopes
de Oliveira-Marques, Virgínia
Hampson, Richard John
Jacinto, António
de Moraes, Luciana Vieira
Martinho, Rui Gonçalo
author_facet Gomes, Teresa Lopes
de Oliveira-Marques, Virgínia
Hampson, Richard John
Jacinto, António
de Moraes, Luciana Vieira
Martinho, Rui Gonçalo
author_sort Gomes, Teresa Lopes
collection PubMed
description Tight junctions (TJ) are formed by transmembrane and intracellular proteins that seal the intercellular space and control selective permeability of epithelia. Integrity of the epithelial barrier is central to tissue homeostasis and barrier dysfunction has been linked to many pathological conditions. TJ support the maintenance of cell polarity through interactions with the Par complex (Cdc42-Par-6-Par-3-aPKC) in which Par-6 is an adaptor and links the proteins of the complex together. Studies have shown that Par-6 overexpression delays the assembly of TJ proteins suggesting that Par-6 negatively regulates TJ assembly. Because restoring barrier integrity is of key therapeutic and prophylactic value, we focus on finding compounds that have epithelial barrier reinforcement properties; we developed a screening platform (theLiTE™) to identify compounds that modulate Par-6 expression in follicular epithelial cells from Par-6-GFP Drosophila melanogaster egg chambers. Hits identified were then tested whether they improve epithelial barrier function, using measurements of transepithelial electrical resistance (TEER) or dye efflux to evaluate paracellular permeability. We tested 2,400 compounds, found in total 10 hits. Here we present data on six of them: the first four hits allowed us to sequentially build confidence in theLiTE™ and two compounds that were shortlisted for further development (myricetin and quercetin). We selected quercetin due to its clinical and scientific validation as a compound that regulates TJ; food supplement formulated on the basis of this discovery is currently undergoing clinical evaluation in gastroesophageal reflux disease (GERD) sufferers.
format Online
Article
Text
id pubmed-8771259
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87712592022-01-21 theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions Gomes, Teresa Lopes de Oliveira-Marques, Virgínia Hampson, Richard John Jacinto, António de Moraes, Luciana Vieira Martinho, Rui Gonçalo Front Pharmacol Pharmacology Tight junctions (TJ) are formed by transmembrane and intracellular proteins that seal the intercellular space and control selective permeability of epithelia. Integrity of the epithelial barrier is central to tissue homeostasis and barrier dysfunction has been linked to many pathological conditions. TJ support the maintenance of cell polarity through interactions with the Par complex (Cdc42-Par-6-Par-3-aPKC) in which Par-6 is an adaptor and links the proteins of the complex together. Studies have shown that Par-6 overexpression delays the assembly of TJ proteins suggesting that Par-6 negatively regulates TJ assembly. Because restoring barrier integrity is of key therapeutic and prophylactic value, we focus on finding compounds that have epithelial barrier reinforcement properties; we developed a screening platform (theLiTE™) to identify compounds that modulate Par-6 expression in follicular epithelial cells from Par-6-GFP Drosophila melanogaster egg chambers. Hits identified were then tested whether they improve epithelial barrier function, using measurements of transepithelial electrical resistance (TEER) or dye efflux to evaluate paracellular permeability. We tested 2,400 compounds, found in total 10 hits. Here we present data on six of them: the first four hits allowed us to sequentially build confidence in theLiTE™ and two compounds that were shortlisted for further development (myricetin and quercetin). We selected quercetin due to its clinical and scientific validation as a compound that regulates TJ; food supplement formulated on the basis of this discovery is currently undergoing clinical evaluation in gastroesophageal reflux disease (GERD) sufferers. Frontiers Media S.A. 2022-01-04 /pmc/articles/PMC8771259/ /pubmed/35069190 http://dx.doi.org/10.3389/fphar.2021.752787 Text en Copyright © 2022 Gomes, Oliveira-Marques, Hampson, Jacinto, de Moraes and Martinho. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gomes, Teresa Lopes
de Oliveira-Marques, Virgínia
Hampson, Richard John
Jacinto, António
de Moraes, Luciana Vieira
Martinho, Rui Gonçalo
theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions
title theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions
title_full theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions
title_fullStr theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions
title_full_unstemmed theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions
title_short theLiTE™: A Screening Platform to Identify Compounds that Reinforce Tight Junctions
title_sort thelite™: a screening platform to identify compounds that reinforce tight junctions
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771259/
https://www.ncbi.nlm.nih.gov/pubmed/35069190
http://dx.doi.org/10.3389/fphar.2021.752787
work_keys_str_mv AT gomesteresalopes theliteascreeningplatformtoidentifycompoundsthatreinforcetightjunctions
AT deoliveiramarquesvirginia theliteascreeningplatformtoidentifycompoundsthatreinforcetightjunctions
AT hampsonrichardjohn theliteascreeningplatformtoidentifycompoundsthatreinforcetightjunctions
AT jacintoantonio theliteascreeningplatformtoidentifycompoundsthatreinforcetightjunctions
AT demoraeslucianavieira theliteascreeningplatformtoidentifycompoundsthatreinforcetightjunctions
AT martinhoruigoncalo theliteascreeningplatformtoidentifycompoundsthatreinforcetightjunctions